Literature DB >> 8203460

Bcl-2 expression in normal endometrium during the menstrual cycle.

A Gompel1, J C Sabourin, A Martin, H Yaneva, J Audouin, Y Decroix, P Poitout.   

Abstract

Bcl-2 is a proto-oncogene initially described in the (14;18) translocation in follicular lymphoma. It has been shown to prolong cell survival by preventing apoptosis. Endometrium undergoes rapid proliferation and differentiation under hormone control and is thus an excellent model to study the hormone dependency of Bcl-2 expression. We studied Bcl-2 expression by an immunohistochemical method in 53 samples of normal endometrium randomly distributed throughout the menstrual cycle, as well as five samples of hyperplastic endometrium. Bcl-2 staining predominated in glandular cells and peaked at the end of the follicular phase. Bcl-2 expression disappeared at the onset of secretory activity. The stroma, surface lining epithelium and arterial vessels also displayed cyclic variations in Bcl-2 expression. These results strongly suggest hormone-dependent regulation of Bcl-2 expression, which could play an important role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203460      PMCID: PMC1887458     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Determinants of messenger RNA stability.

Authors:  G Brawerman
Journal:  Cell       Date:  1987-01-16       Impact factor: 41.582

2.  Atrophy and apoptosis in the cyclical human endometrium.

Authors:  D Hopwood; D A Levison
Journal:  J Pathol       Date:  1976-07       Impact factor: 7.996

3.  Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

Authors:  J C Reed; Y Tsujimoto; J D Alpers; C M Croce; P C Nowell
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

4.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

5.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

6.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Authors:  M Colombel; F Symmans; S Gil; K M O'Toole; D Chopin; M Benson; C A Olsson; S Korsmeyer; R Buttyan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

Authors:  Y Tsujimoto; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Hormonal regulation of cell death in rabbit uterine epithelium.

Authors:  S Nawaz; M P Lynch; P Galand; L E Gerschenson
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

9.  Biochemical evidence for programmed cell death in rabbit uterine epithelium.

Authors:  R J Rotello; M B Hocker; L E Gerschenson
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

10.  The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.

Authors:  Z Chen-Levy; J Nourse; M L Cleary
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

View more
  14 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival.

Authors:  P Stattin; J E Damber; L Karlberg; H Nordgren; A Bergh
Journal:  Urol Res       Date:  1996

3.  Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis.

Authors:  B Formby; T S Wiley
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

4.  BCL2 regulates neural differentiation.

Authors:  K Z Zhang; J A Westberg; E Hölttä; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

5.  Expression of apoptotic factors in vaginal tissues from women with urogenital prolapse.

Authors:  Yan Wen; Jason Yen-Ping Ho; Mary Lake Polan; Bertha Chen
Journal:  Neurourol Urodyn       Date:  2011-06-14       Impact factor: 2.696

6.  Alteration of apoptosis-related genes in postmenopausal women with uterine prolapse.

Authors:  Bahadir Saatli; Sefa Kizildag; Erkan Cagliyan; Erbil Dogan; Ugur Saygili
Journal:  Int Urogynecol J       Date:  2014-03-11       Impact factor: 2.894

7.  Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia.

Authors:  M Saegusa; Y Takano; I Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication.

Authors:  Lucia Nencioni; Giovanna De Chiara; Rossella Sgarbanti; Donatella Amatore; Katia Aquilano; Maria E Marcocci; Annalucia Serafino; Maria Torcia; Federico Cozzolino; Maria R Ciriolo; Enrico Garaci; Anna T Palamara
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

9.  Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma.

Authors:  I Okayasu; M Saegusa; M Fujiwara; Y Hara; N R Rose
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Association of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese population.

Authors:  Tsogzolmaa Dorjgochoo; Yong-Bing Xiang; Jirong Long; Jiajun Shi; Sandra Deming; Wang-Hong Xu; Hui Cai; Jiarong Cheng; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.